First Horizon Advisors’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.7K | Buy |
868
+498
| +135% | +$25K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $21.7K | Buy |
370
+16
| +5% | +$1.08K | ﹤0.01% | 1291 |
|
|
2024
Q4 | $25.5K | Sell |
354
-107
| -23% | -$7.86K | ﹤0.01% | 1236 |
|
|
2024
Q3 | $36.9K | Sell |
461
-8
| -2% | -$601 | ﹤0.01% | 1122 |
|
|
2024
Q2 | $33.6K | Sell |
469
-20
| -4% | -$1.47K | ﹤0.01% | 1093 |
|
|
2024
Q1 | $34.4K | Sell |
489
-32
| -6% | -$2.29K | ﹤0.01% | 1127 |
|
|
2023
Q4 | $40.2K | Buy |
521
+191
| +58% | +$12.6K | ﹤0.01% | 1043 |
|
|
2023
Q3 | $22.5K | Sell |
330
-5
| -1% | -$395 | ﹤0.01% | 1210 |
|
|
2023
Q2 | $27.3K | Buy |
335
+5
| +2% | +$402 | ﹤0.01% | 1149 |
|
|
2023
Q1 | $24.5K | Buy |
330
+39
| +13% | +$3.01K | ﹤0.01% | 1186 |
|
|
2022
Q4 | $24.1K | Buy |
291
+23
| +9% | +$1.83K | ﹤0.01% | 1192 |
|
|
2022
Q3 | $18K | Buy |
268
+92
| +52% | +$7.95K | ﹤0.01% | 1281 |
|
|
2022
Q2 | $14K | Buy |
176
+136
| +340% | +$12.7K | ﹤0.01% | 1445 |
|
|
2022
Q1 | $4K | Sell |
40
-136
| -77% | -$14K | ﹤0.01% | 1352 |
|
|
2021
Q4 | $23K | Hold |
176
| – | – | ﹤0.01% | 1229 |
|
|
2021
Q3 | $20K | Sell |
176
-32
| -15% | -$3.89K | ﹤0.01% | 1290 |
|
|
2021
Q2 | $23K | Sell |
208
-24
| -10% | -$2.53K | ﹤0.01% | 1074 |
|
|
2021
Q1 | $22K | Sell |
232
-392
| -63% | -$35.8K | ﹤0.01% | 1047 |
|
|
2020
Q4 | $49K | Hold |
624
| – | – | ﹤0.01% | 612 |
|
|
2020
Q3 | $38K | Buy |
624
+140
| +29% | +$9.11K | ﹤0.01% | 626 |
|
|
2020
Q2 | $32K | Hold |
484
| – | – | ﹤0.01% | 651 |
|
|
2020
Q1 | $22K | Buy |
484
+4
| +0.8% | +$200 | ﹤0.01% | 711 |
|
|
2019
Q4 | $26K | Hold |
480
| – | – | ﹤0.01% | 769 |
|
|
2019
Q3 | $23K | Buy |
480
+128
| +36% | +$6.42K | ﹤0.01% | 801 |
|
|
2019
Q2 | $18K | Hold |
352
| – | – | ﹤0.01% | 905 |
|
|
2019
Q1 | $17K | Hold |
352
| – | – | ﹤0.01% | 895 |
|
|
2018
Q4 | $12K | Hold |
352
| – | – | ﹤0.01% | 971 |
|
|
2018
Q3 | $17K | Buy |
352
+4
| +1% | +$177 | ﹤0.01% | 943 |
|
|
2018
Q2 | $13K | Hold |
348
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q1 | $13K | Hold |
348
| – | – | ﹤0.01% | 922 |
|
|
2017
Q4 | $12K | Buy |
348
+104
| +43% | +$3.3K | ﹤0.01% | 985 |
|
|
2017
Q3 | $7K | Hold |
244
| – | – | ﹤0.01% | 1121 |
|
|
2017
Q2 | $7K | Sell |
244
-20
| -8% | -$547 | ﹤0.01% | 1087 |
|
|
2017
Q1 | $7K | Hold |
264
| – | – | ﹤0.01% | 1133 |
|
|
2016
Q4 | $6K | Hold |
264
| – | – | ﹤0.01% | 1114 |
|
|
2016
Q3 | $6K | Hold |
264
| – | – | ﹤0.01% | 1105 |
|
|
2016
Q2 | $7K | Hold |
264
| – | – | ﹤0.01% | 1058 |
|
|
2016
Q1 | $6K | Buy |
264
+4
| +2% | +$88 | ﹤0.01% | 1106 |
|
|
2015
Q4 | $5K | Buy |
260
+40
| +18% | +$912 | ﹤0.01% | 1052 |
|
|
2015
Q3 | $5K | Hold |
220
| – | – | ﹤0.01% | 1183 |
|
|
2015
Q2 | $5K | Sell |
220
-228
| -51% | -$5.69K | ﹤0.01% | 1214 |
|
|
2015
Q1 | $11K | Hold |
448
| – | – | ﹤0.01% | 1018 |
|
|
2014
Q4 | $10K | Hold |
448
| – | – | ﹤0.01% | 1043 |
|
|
2014
Q3 | $10K | Hold |
448
| – | – | ﹤0.01% | 1074 |
|
|
2014
Q2 | $10K | Buy |
+448
| New | +$9.9K | ﹤0.01% | 1040 |
|
Other funds holding TECH
First Horizon Advisors's TECH Position: Q2 2025 in Review
First Horizon Advisors increased its Bio-Techne (TECH) stake by 135% in Q2 2025, buying an estimated $25K and bringing the position to 868 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.
First Horizon Advisors first reported a position in TECH in Q2 2014 and has held it in 45 quarters since. The position peaked at $49K in Q4 2020. 555 funds tracked by Wall St. Rank hold TECH as of Q2 2025.
- First Horizon Advisors held 868 shares of Bio-Techne worth $44.7K as of Q2 2025.
- First Horizon Advisors bought 498 Bio-Techne shares in Q2 2025, an estimated $25K.
- Bio-Techne made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1068 holding.
- First Horizon Advisors first reported a position in Bio-Techne in Q2 2014 and has held it in 45 quarters since.
- First Horizon Advisors's Bio-Techne position peaked at $49K in Q4 2020.
- 555 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.